Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

354 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Profiling severe asthma: Any relevance for age? An analysis from Severe Asthma Network Italy (SANI) cohort.
Caminati M, Marcon A, Vaia R, Senna G, Maule M, Marchetti P, Miotti J, Argentino G, Blasi F, Canonica GW, Heffler EM, Paggiaro P, Vianello A, Guarnieri G; SANI study group. Caminati M, et al. Among authors: paggiaro p. World Allergy Organ J. 2024 Jul 29;17(8):100941. doi: 10.1016/j.waojou.2024.100941. eCollection 2024 Aug. World Allergy Organ J. 2024. PMID: 39176287 Free PMC article.
Asthma control in severe asthmatics under treatment with omalizumab: a cross-sectional observational study in Italy.
Novelli F, Latorre M, Vergura L, Caiaffa MF, Camiciottoli G, Guarnieri G, Matucci A, Macchia L, Vianello A, Vultaggio A, Celi A, Cazzola M, Paggiaro P; Xolair Italian Study Group. Novelli F, et al. Among authors: paggiaro p. Pulm Pharmacol Ther. 2015 Apr;31:123-9. doi: 10.1016/j.pupt.2014.09.007. Epub 2014 Sep 30. Pulm Pharmacol Ther. 2015. PMID: 25281265
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial.
Papi A, Marku B, Scichilone N, Maestrelli P, Paggiaro P, Saetta M, Nava S, Folletti I, Bertorelli G, Bertacco S, Contoli M, Plebani M, Barbaro MPF, Spanevello A, Aliani M, Pannacci M, Morelli P, Beghé B, Fabbri LM; AIFASMA Study Group. Papi A, et al. Among authors: paggiaro p. Lancet Respir Med. 2015 Feb;3(2):109-119. doi: 10.1016/S2213-2600(14)70266-8. Epub 2014 Dec 4. Lancet Respir Med. 2015. PMID: 25481378 Clinical Trial.
Focus on audiologic impairment in eosinophilic granulomatosis with polyangiitis.
Seccia V, Fortunato S, Cristofani-Mencacci L, Dallan I, Casani AP, Latorre M, Paggiaro P, Bartoli ML, Sellari-Franceschini S, Baldini C. Seccia V, et al. Among authors: paggiaro p. Laryngoscope. 2016 Dec;126(12):2792-2797. doi: 10.1002/lary.25964. Epub 2016 Apr 14. Laryngoscope. 2016. PMID: 27075698
Reply.
Paggiaro P, Latorre M. Paggiaro P, et al. J Allergy Clin Immunol Pract. 2016 Jul-Aug;4(4):793. doi: 10.1016/j.jaip.2016.04.025. J Allergy Clin Immunol Pract. 2016. PMID: 27393790 No abstract available.
Effects of omalizumab in severe asthmatics across ages: A real life Italian experience.
Sposato B, Scalese M, Latorre M, Scichilone N, Matucci A, Milanese M, Masieri S, Rolla G, Steinhilber G, Rosati Y, Vultaggio A, Folletti I, Baglioni S, Bargagli E, Di Tomassi M, Pio R, Pio A, Maccari U, Maggiorelli C, Migliorini MG, Vignale L, Pulerà N, Carpagnano GE, Foschino Barbaro MP, Perrella A, Paggiaro PL. Sposato B, et al. Among authors: paggiaro pl. Respir Med. 2016 Oct;119:141-149. doi: 10.1016/j.rmed.2016.09.005. Epub 2016 Sep 4. Respir Med. 2016. PMID: 27692136 Free article.
354 results